Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues.

Bodei, L; Pepe, G; Paganelli, G

Bodei, L; Pepe, G; Paganelli, G.

Affiliation

Bodei L; Nuclear Medicine Divisions, European Instituteof Oncology, Milano, Italy.

Eur Rev Med Pharmacol Sci ; 14(4): 347-51, 2010 Apr.

Article in En | MEDLINE | ID: mdl-20496546

Subject(s)

Antineoplastic Agents/therapeutic use; Neuroendocrine Tumors/radiotherapy; Radioisotopes/therapeutic use; Receptors, Peptide/drug effects; Somatostatin/analogs & derivatives; Somatostatin/therapeutic use; Antineoplastic Agents/adverse effects; Humans; Lutetium/therapeutic use; Octreotide/analogs & derivatives; Octreotide/therapeutic use; Radioisotopes/adverse effects; Radiopharmaceuticals/therapeutic use; Somatostatin/adverse effects; Yttrium Radioisotopes/therapeutic use

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Radioisotopes / Somatostatin / Receptors, Peptide / Neuroendocrine Tumors / Antineoplastic Agents Limits: Humans Language: En Year: 2010 Type: Article

Search on Google

XML

PubMed Links